- Home
- LAZR vs AQST Comparison
LAZR vs AQST Comparison
Compare LAZR & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAZR
- AQST
- Stock Information
- Founded
- LAZR 2012
- AQST 2004
- Country
- LAZR United States
- AQST United States
- Employees
- LAZR N/A
- AQST N/A
- Industry
- LAZR Auto Parts:O.E.M.
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- LAZR Consumer Discretionary
- AQST Health Care
- Exchange
- LAZR Nasdaq
- AQST Nasdaq
- Market Cap
- LAZR 246.4M
- AQST 274.4M
- IPO Year
- LAZR N/A
- AQST 2018
- Fundamental
- Price
- LAZR $5.22
- AQST $2.86
- Analyst Decision
- LAZR Hold
- AQST Strong Buy
- Analyst Count
- LAZR 8
- AQST 7
- Target Price
- LAZR $42.56
- AQST $10.57
- AVG Volume (30 Days)
- LAZR 3.7M
- AQST 1.3M
- Earning Date
- LAZR 03-20-2025
- AQST 03-05-2025
- Dividend Yield
- LAZR N/A
- AQST N/A
- EPS Growth
- LAZR N/A
- AQST N/A
- EPS
- LAZR N/A
- AQST N/A
- Revenue
- LAZR $75,395,000.00
- AQST $57,561,000.00
- Revenue This Year
- LAZR $60.59
- AQST N/A
- Revenue Next Year
- LAZR $109.56
- AQST $39.51
- P/E Ratio
- LAZR N/A
- AQST N/A
- Revenue Growth
- LAZR 8.05
- AQST 13.79
- 52 Week Low
- LAZR $4.48
- AQST $2.24
- 52 Week High
- LAZR $34.80
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- LAZR 45.18
- AQST 45.84
- Support Level
- LAZR $5.35
- AQST $3.05
- Resistance Level
- LAZR $6.83
- AQST $3.24
- Average True Range (ATR)
- LAZR 0.91
- AQST 0.19
- MACD
- LAZR -0.08
- AQST 0.01
- Stochastic Oscillator
- LAZR 15.45
- AQST 22.06
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and advanced Technologies and Services. The majority of revenue is earned from the Autonomy Solutions segment which engaged in the design, manufacturing, and sale of LiDAR sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries and advanced Technologies and Services provides semiconductors and related components, as well as design, test and consulting services to the Autonomy Solutions segment and various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.